We speculate that inhibiting miR-31-5p to increase FNDC5 may be a therapeutic strategy with some unique advantages in oxidative stress attenuation, vascular remodeling, and hypertension with obesity, diabetes, and atherosclerosis. This evidence concerns the gene FNDC5 and Hypertension.